Home›Search›Expert Opinion on Emerging Drugs

Expert Opinion on Emerging Drugs

Taylor and Francis Ltd. · United Kingdom · Est. 1997

ISSN1472-8214eISSN1744-7623

SJR Q2✓ WOS SCIE✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.908

H-Indexi

SNIPi

0.538

Total Worksi

1,014

Total Citationsi

21,385

2yr Mean Citednessi

4.84

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Pharmacology & Pharmacy; Pharmacology; Pharmacology (medical).

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1997

FrequencyBiannual

StatusActive (last: 2025)

Total Publications1,014

Publisher OrgTaylor & Francis

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1472-8214 / 1744-7623

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

471

2019

875

2020

468

2021

361

2022

204

2023

291

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

PharmacologyQ2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)

Research Topics (OpenAlex)

Asthma and respiratory diseasesRetinal Diseases and TreatmentsCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsCAR-T cell therapy researchRheumatoid Arthritis Research and TherapiesPsoriasis: Treatment and PathogenesisHER2/EGFR in Cancer ResearchChronic Lymphocytic Leukemia ResearchPhosphodiesterase function and regulation

Frequently asked questions about Expert Opinion on Emerging Drugs

Is Expert Opinion on Emerging Drugs a predatory journal?

PubScope has no integrity flags on record for Expert Opinion on Emerging Drugs: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Expert Opinion on Emerging Drugs?

Expert Opinion on Emerging Drugs is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.84.

Is Expert Opinion on Emerging Drugs indexed in Scopus and Web of Science?

Expert Opinion on Emerging Drugs is indexed in Web of Science, Scopus.

What is the aims and scope of Expert Opinion on Emerging Drugs?